太阳能ETF-Guggenheim TAN 深 沪
等待开盘 10-02 09:30:00 美东时间
45.08
+1.450
+3.32%
华盛通- 最 高45.3203
- 今 开44.06
- 成交量 83.93万股
- 最 低 44.06
- 昨 收 43.63
- 总市值 8.08亿
- 52周最高 45.3203
- 市盈率 静 --
- 换手率 4.68%
- 52周最低 25.53
- 委 比 0.00%
- 总股本 1792.83万
- 历史最高 125.7667
- 量 比 1.48
- 振 幅 2.89%
- 历史最低 15.125
- 每 手 1
- 风险率 4.02%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Century Complete to Open Two New Communities in Spartanburg, SC
Frey Creek and Riverdale Hills are anticipated to open this fall, with new homes starting from the mid $200s SPARTANBURG, S.C., Oct. 1, 2025 /PRNewswire/ -- Century Communities, Inc. (NYSE: ...
今天 00:38
Natrelle® Awarded Supplier Agreement from Vizient
This agreement grants Vizient clients enhanced access to Natrelle®, the broadest selection of breast implant options on the market. IRVINE, Calif., Oct. 1, 2025 /PRNewswire/ -- Allergan Aest...
10-01 20:00
PROSPERITY BANCSHARES, INC.® TO ACQUIRE SOUTHWEST BANCSHARES, INC. IN SAN ANTONIO, TEXAS
HOUSTON and SAN ANTONIO, Oct. 1, 2025 /PRNewswire/ -- Prosperity Bancshares, Inc.® (NYSE: PB) ("Prosperity"), the parent company of Prosperity Bank®, and Southwest Bancshares, Inc. ("Southwe...
10-01 18:30
Lifeway and Danone Sign Cooperation Agreement
New Independent Directors to be Added Stockholders' Agreement Litigation is Stayed Lifeway is Evaluating Capital Allocation Alternatives to Maximize Value Danone Will Not Vote or Deliver Co...
10-01 05:10
Damon Provides Operational Business Update and Reports Fiscal Year 2025 Results
Follows recent announcement of Damon's $30 million Reg A+ offering to advance its personal mobility products and AI-enabled connected vehicle strategy at https://invest.damon.com VANCOUVER,...
09-30 21:00
LENZ Therapeutics Announces Commercial Product Availability of VIZZ™ in the United States
VIZZ sample distribution initiated nationwide to Eye Care Professionals Commercial product shipments to be initiated in October to consumers with broad product availability by mid-Q4 2025 VI...
09-30 20:05
AbbVie Announces UK Pricing Strategy for ELAHERE® (mirvetuximab soravtansine-gynx)
The list price will be consistent with the United States to reflect the value of the innovation AbbVie is committed to ensuring that developed nations fully recognize the value of our medici...
09-29 21:00
CONTANGO PROVIDES UPDATE ON FINANACING AND EXPLORATION PLANS
FAIRBANKS, Alaska, Sept. 26, 2025 /PRNewswire/ - Contango ORE, Inc. ("Contango" or the "Company") (NYSE American: CTGO), announces that it will hold a webinar on Friday, September 26, 2025 a...
09-26 22:07
ESSA Pharma Inc. Amends Agreement with XenoTherapeutics
Shareholders expected to receive approximately $0.12 per share in cash upon closing of transaction and up to approximately $0.14 per CVR under revised terms Further Adjourns Special Meeting ...
09-24 18:00
Elanco Announces FDA Approves Improved Zenrelia™ (ilunocitinib tablets) Label, Removing Vaccine-Induced Disease Language
FDA now concludes "the totality of evidence supports removal of the risk of fatal vaccine-induced disease from modified live virus vaccines from the labeling"i Further evaluation of suppleme...
09-23 18:27
